A detailed history of Pinz Capital Management, LP transactions in Ardelyx, Inc. stock. As of the latest transaction made, Pinz Capital Management, LP holds 16,400 shares of ARDX stock, worth $105,452. This represents 0.04% of its overall portfolio holdings.

Number of Shares
16,400
Previous 24,500 33.06%
Holding current value
$105,452
Previous $14,000 42.86%
% of portfolio
0.04%
Previous 0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022

SELL
$0.59 - $1.44 $4,779 - $11,664
-8,100 Reduced 33.06%
16,400 $20,000
Q2 2022

Aug 15, 2022

BUY
$0.51 - $1.17 $12,495 - $28,665
24,500 New
24,500 $14,000
Q3 2021

Nov 15, 2021

SELL
$1.27 - $8.17 $20,193 - $129,903
-15,900 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$6.55 - $8.98 $104,145 - $142,782
15,900 New
15,900 $121,000
Q1 2020

May 12, 2020

SELL
$4.35 - $8.79 $885,224 - $1.79 Million
-203,500 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$4.23 - $8.29 $860,805 - $1.69 Million
203,500 New
203,500 $1.53 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $994M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Pinz Capital Management, LP Portfolio

Follow Pinz Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pinz Capital Management, LP with notifications on news.